Stavudine

Specifications

3056-17-5CAS Number

641-374-0EC Number

1-[(2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]-5-methylpyrimidine-2,4-dioneIUPAC Name

C10H12N2O4Chemical Formula

224.21 g/molMolecular Weight

stavudine; 3056-17-5; sanilvudine; Zerit; 2',3'-Didehydro-3'-deoxythymidine; Estavudina; Stavudinum; Thymidine, 2',3'-didehydro-3'-deoxy-; Zerit Xr; BMY-27857; 1-((2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione; D 4T (nucleoside); 3'-Deoxy-2'-thymidinene; 2',3'-Didehydro-3'-deoxythimidine; 3'-Deoxy-2',3'-didehydrothymidine; BMY 27857; DTXSID1023819; Dideoxydidehydrothymidine; BO9LE4QFZF; 1-(2,3-Dideoxy-beta-D-glycero-pent-2-enofuranosyl)thymine; Stavudine (d4T); BMY27857; Stavudine (dt4); 2'-Thymidinene, 3'-deoxy-; NSC-759897; 1-[(2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]-5-methylpyrimidine-2,4-dione; NSC-163661; DTXCID803819; 1-[(2R,5S)-5-(HYDROXYMETHYL)-2,5-DIHYDROFURAN-2-YL]-5-METHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE; CHEBI:63581; NSC163661; 1-[(2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]-5-methylpyrimidine-2,4(1H,3H)-dione; 2',3' Didehydro 3' deoxythymidine; 2',3'-Didehydro-2',3'-dideoxythmidine; 1-((2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl)-5-methylpyrimidine-2,4-dione; 1-((2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl)-5-methyl-1,2,3,4-tetrahydropyrimidine-2,4-dione; Didehydrodeoxythymidine; RefChem:57733; 1-(2,3-dideoxy-beta-glycero-pent-2-enofuranosyl)thymine; Thymine, 1-(2,3-dideoxy-beta-D-glycero-pent-2-enofuranosyl)-(7CI,8CI); Lion; d4T; Stavudinum [INN-Latin]; Estavudina [INN-Spanish]; ddeThd; MFCD00132921; Sanilvudine (JAN); D-4T; STV; CHEMBL991; Zerut XR; MLS000028546; NCGC00023212-07; SMR000058350; SANILVUDINE [JAN]; NSC 163661; 1-[(2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]-5-methyl-pyrimidine-2,4-dione; Stavudine [USAN:BAN:INN]; 1-(2,3-Dideoxy-.beta.-D-glycero-pent-2-enofuranosyl)thymine; D 4T; ddeTyd; 1-(cis-5-(Hydroxymethyl)-2,5-dihydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione; 220020-60-0; CAS-3056-17-5; Zerit(TM); Zerit (TN); HSDB 7338; SR-01000075802; UNII-BO9LE4QFZF; Stavudine (USAN/INN); BRN 0618327; D4T & GM-CSF; Stavudine RS; Stavudine CRS; 2',3'-Didehydro-3'-deoxy-thymidine; Stavudine [USAN:USP:INN:BAN]; D4TMBY-27857-3; Stavudine (Standard); 1-(2,3-Dideoxy-beta-D-glycero-2-pentenofuranosyl)thymine; STAVUDINE [INN]; STAVUDINE [MI]; STAVUDINE [HSDB]; STAVUDINE [USAN]; Opera_ID_1281; STAVUDINE [MART.]; D 1413; cid_5155; STAVUDINE [USP-RS]; STAVUDINE [WHO-DD]; STAVUDINE [WHO-IP]; 3''-deoxy-2''-thymidine; Lopac0_000336; SCHEMBL38661; STAVUDINE [EMA EPAR]; cid_18283; MLS000759504; MLS001055348; MLS001077292; MLS001424091; MLS006011922; BIDD:GT0082; Stavudine - Bio-X trade mark; orb1225361; 2',3'-Anhydrothymidine; d4T; STAVUDINE [EP IMPURITY]; STAVUDINE [ORANGE BOOK]; STAVUDINE [EP MONOGRAPH]; GTPL12678; HY-B0116R; STAVUDINE [USP MONOGRAPH]; STAVUDINUM [WHO-IP LATIN]; GLXC-07997; HMS2051O20; HMS2234C10; HMS3039O05; HMS3259L21; HMS3261C13; HMS3428C07; HMS3714N22; Pharmakon1600-01502339; STAVUDINE (D4T) [VANDF]; STAVUDINE (DT4) [VANDF]; HY-B0116; Tox21_110886; Tox21_201393; Tox21_300583; Tox21_500336; BDBM50013111; EBC-07706; NSC759897; s7603; Stavudine for system suitability CRS; Stavudine(Zidovudine EP Impurity A); STK801888; Zidovudine EP Impurity A; Stavudine; AKOS005622554; Tox21_110886_1; AC-5263; CCG-100902; CS-1872; DB00649; KS-1115; LP00336; NC00152; NC00684; ND07118; SDCCGSBI-0050324.P002; Stavudine 100 |Ig/mL in Acetonitrile; ZIDOVUDINE IMPURITY A [WHO-IP]; 1-((2R,5S)-5-Hydroxymethyl-2,5-dihydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione; 2'',3''-didehydro-3''-deoxythymidine; 3''-deoxy-2'',3''-didehydrothymidine; 3'-Deoxy-2',3'-didehydro-D-thymidine; NCGC00023212-03; NCGC00023212-04; NCGC00023212-05; NCGC00023212-08; NCGC00023212-09; NCGC00023212-10; NCGC00023212-11; NCGC00023212-12; NCGC00023212-13; NCGC00023212-14; NCGC00023212-25; NCGC00023212-30; NCGC00023212-31; NCGC00254372-01; NCGC00258944-01; NCGC00261021-01; Stavudine 100 microg/mL in Acetonitrile; 1-[5-(hydroxymethyl)-2,5-dihydro-2-furanyl]-5-methyl-2,4(1H,3H)-pyrimidinedione & Colony-stimulating factor 2; BD164571; SMR000673569; SY057970; 2',3'-didehydro-2',3'-dideoxythymidine; Thymidine, 2',3'-didehydro-, 3'-deoxy-; ZIDOVUDINE IMPURITY A [EP IMPURITY]; D3580; EU-0100336; NS00002353; 2'',3''-dideoxy-2'',3''-didehydrothymidine; C07312; D00445; EN300-120634; AB00383018_18; F404709; Q423984; SR-01000075802-1; SR-01000075802-4; 2',3'-Didehydro-3'-deoxythymidine, >=98% (TLC); BRD-K93880783-001-26-6; Z1530425068; Stavudine, European Pharmacopoeia (EP) Reference Standard; Stavudine, United States Pharmacopeia (USP) Reference Standard; Thymine, 1-(2,3-dideoxy-beta-D-glycero-pent-2-enofuranosyl)-; 1-(5-Hydroxymethyl-2,5-dihydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione; 1-(5-Hydroxymethyl-2,5-dihydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione (ddeThd); 3'- Azido-3'-deoxythymidine & Granulocyte-macrophage colony-stimulating factor; Stavudine for system suitability, European Pharmacopoeia (EP) Reference StandardSynonyms